GlassScriptPhysician profile
Lam Nguyen Chu
NPI 1497914816
$2,807.30
in general payments reported to CMS, 2019-2025
35 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $510 · 2021: $357 · 2022: $255 · 2023: $639 · 2024: $306 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $366.53 | 2019-2024 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $289.88 | 2020-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $226.31 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $189.95 | 2023-2025 | Myfembree |
| Biogen, INC. | $155.51 | 2024-2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $134.21 | 2019-2020 | |
| Millicent US INC | $129.75 | 2020-2023 | Femring, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $128.55 | 2019-2021 | |
| Medtronic, INC. | $113.89 | 2023 | Polysorb, Truclear, V-Loc 180 |
| Hologic Sales and Service, LLC | $98.35 | 2020-2023 | Affirm Prone Biopsy System, Thinprep 2000 Processor, Aptima |
| Mayne Pharma Commercial LLC | $95.61 | 2022-2025 | |
| Coopersurgical, INC. | $92.15 | 2019-2023 | Paragard T 380a |
| Pfizer INC. | $88.83 | 2022-2024 | |
| Allergan, INC. | $82.84 | 2019-2020 | |
| Lupin INC. | $64.09 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $59.67 | 2020-2021 | |
| Organon LLC | $42.67 | 2022-2024 | |
| Myovant Sciences INC. | $41.61 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $40.71 | 2020-2023 | |
| Evofem Biosciences, INC. | $39.60 | 2020-2021 | |
| Gynesonics, INC. | $36.98 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $35.69 | 2021 | |
| Mylan Pharmaceuticals INC. | $29.46 | 2019-2022 | |
| Ethicon US, LLC | $27.33 | 2020-2023 | Ethicon, Stratafix, Surgiflo Hemostatic Matrix |
| Agile Therapeutics, INC. | $26.56 | 2022-2023 | Twirla |
| Duchesnay USA Incorporated | $23.27 | 2019 | |
| Acessa Health INC. | $22.35 | 2019 | |
| Roche Diagnostics Corporation | $19.27 | 2019 | |
| Biom'Up France Sas | $17.86 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.45 | 2021 | |
| Innovation Technologies INC | $17.37 | 2025 | Irrisept |
| Medicem INC. | $16.11 | 2020 | |
| Renovia INC | $13.47 | 2019 | |
| Shield Therapeutics INC | $12.53 | 2022 | |
| Vertical Pharmaceuticals, LLC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lam Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.